Remarkably, the four tumors that were initially suspected to be tRCC but lacked TFE3 fusion clustered with ccRCC, confirming that TFE3 fusion is a strong determinant of tRCC. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.